Our research shapes the future of care
Interested in being part of a study? Learn about how to participate.
Find Studies
-
A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects with Chronic Spinal Cord Injury – A Randomized, Double-Blind, Placebo-Controlled MulticEnter Phase 3 Trial (RESTORE)
Daily subcutaneous injections of NVG-291 to treat of chronic tetraplegia.
Principal Investigator: Wes Chay
-
ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury (SCI): Empower BP
Empower BP is recruiting people with symptomatic blood pressure instability following a chronic SCI.
Principal Investigator: Wes Chay
-
Activating Spinal Circuits to Improve Walking, Balance, Strength, and Reduce Spasticity
Evaluating effects of accessible training with spinal stimulation on walking, balance, strength.
Principal Investigator: Edelle Field-Fote
-
Influence of Spinal Stimulation Frequency on Spasticity, Motor Control, and Pain After Spinal Cord Injury (SCI)
Testing different doses of noninvasive stimulation to improve spasticity, strength, and pain in SCI.
Principal Investigator: Edelle Field-Fote